Recent abolon transactions

Abolon advises VITAL Zahnärzte on their acquisition of ARS Dentalis

VITAL Zahnärzte today signed sales and purchase agreements with the entities comprising the ARS Dentalis group of dentistry practices and dental laboratories. The transaction was announced this morning and is subject to the usual approval procedures. The purchase price was not disclosed. The ARS Dentalis practices will be renamed VITAL Zahnärzte. With 4 large dental clinics in Southern Germany, the group offers the full range of dentistry services with a focus on high-quality treatment, fully digitalized processes, local lab support in each practice and patient-friendly opening hours (365 days per year). VITAL Zahnärzte intend to expand their large-practice, dentist-friendly model (“developed by dentists for dentists”) to other locations over the coming years. Abolon advised VITAL Zahnärzte, building on Abolon’s expertise in M&A, financing, insolvency procedures and dentistry. This transaction follows other successful Abolon transactions in the UK/European out-patient healthcare practice sector incl. Amethyst Radiotherapy (radiotherapy, 2019), RADx (diagnostic imaging, 2017), Dr. Hansen (dentistry, 2016), Corius (dermatology, 2016), Alanta/Zytoservice (oncology, 2016), Amedes (medical labs/gynaecology/IVF, 2015) and Medica Group (teleradiology).

Read more

Healthcare insights

How will new landmark legislation affect Germany’s private hospital groups

The new Hospital Structure Act could force small, low quality public sector hospitals to the wall. But it could also cap growth for big private operators. We examine likely scenarios.

Read more

Healthcare deal of the month

December 2015: Etac acquires Convaid

The Deal: In December 2015, Etac, a Sweden-based developer and manufacturer of mobility solutions and rehab products, acquired Convaid Products

Read more

WELCOME TO ABOLON

Abolon is a strategy consulting and corporate finance company with an exclusive focus on the healthcare sector.

We pride ourselves on our specialist insights into the various segments of the healthcare markets in Europe and beyond.

Our global network in the healthcare sector provides us with unmatched dealflow of large and mid-sized healthcare opportunities.

Facts & figures

  • Healthcare forms an enormous ...
  • Stable healthcare sector attracts ...
  • The global pharmaceutical market ...
  • The healthcare sector offers ...
  • Abolon has advised on ...
  • Healthcare forms an enormous part of developed country's economy, contributing over 10 percent of gross domestic product (GDP).
  • Stable healthcare sector attracts record private equity investments.
  • The global pharmaceutical market is expected to grow from 995 $bn in 2011 to 1160 $bn in 2016
  • The healthcare sector offers numerous opportunities at low risk
  • Abolon has advised on 4 successful healthcare transactions in the last 18 months.